Abstract
This study was undertaken to evaluate the effects of n-3 fatty acid supplementation on blood glucose, lipid profile and cytokines in humans. Twenty adult healthy subjects were supplemented with 1g/day fish oil concentrate capsules for 2 weeks. Fasting blood samples were taken at baseline and again after 2 week intervention. Fish oil supplementation significantly lowered fasting serum concentrations of total cholesterol, triacylglycerol, very low density lipoprotein and low density lipoprotein (P < 0.01). Also high density lipoprotein increased significantly compared with baseline value (P < 0.01). Fish oil did not significantly altere the fasting blood glucose concentration but significantly reduced the serum cytokines (P < 0.001). This study demonstrated that eicosapentanoic acid (EPA) and docosahexaenoic acid (DHA) supplementation altered serum lipids, lipoprotein and cytokine concentrations in normal human subjects even at the small dose of 660 mg of EPA plus DHA per day. It appears that EPA plus DHA can be a safe and perhaps beneficial supplement to inflammatory diseases.
Key Words: n-3 fatty acid, Blood Glucose, Lipid profile, Cytokines
Full Text
The Full Text of this article is available as a PDF (49.5 KB).
References
- 1.Holub D.J., Holub B.J. Omega-3 fatty acids from fish oils and cardiovascular disease. Mol Cell Biochem. 2004;263:217–225. doi: 10.1023/B:MCBI.0000041863.11248.8d. [DOI] [PubMed] [Google Scholar]
- 2.Zeman M., Zak A., Vecka M. n-3 fatty acid supplementation decreases plasma homocysteine in diabetic dyslipidemia treated with statin-fibrate combination. J Nutr Biochem. 2006;17:379–384. doi: 10.1016/j.jnutbio.2005.08.007. [DOI] [PubMed] [Google Scholar]
- 3.Macdonald A. Omega-3 fatty acids as adjunctive therapy in Crohns disease. Gastroenterol Nurs. 2006;29:295–301. doi: 10.1097/00001610-200607000-00005. [DOI] [PubMed] [Google Scholar]
- 4.Peet M., Stokes C. Omega-3 fatty acids in the treatment of psychiatric disorders. Drugs. 2005;65:1051–1059. doi: 10.2165/00003495-200565080-00002. [DOI] [PubMed] [Google Scholar]
- 5.Salem N., Simopoulos A.P., Galli C., Lagarde M., Knapp H.R. Fatty acids and lipids from cell biology to human disease. Lipids. 1996;31:321–326. doi: 10.1007/BF02637068. [DOI] [Google Scholar]
- 6.Balk E.M., Lichtenstein A.H., Chung M. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: A systematic review. Atherosclerosis. 2006;189:19–30. doi: 10.1016/j.atherosclerosis.2006.02.012. [DOI] [PubMed] [Google Scholar]
- 7.Calder P.C. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr. 2006;83:1505–1519. doi: 10.1093/ajcn/83.6.1505S. [DOI] [PubMed] [Google Scholar]
- 8.Blok W.L., Katan M.B., Meer J.W. Modulation of inflammation and cytokine production by dietary(n-3) fatty acids. J Nutr. 1996;126:1515–1533. doi: 10.1093/jn/126.6.1515. [DOI] [PubMed] [Google Scholar]
- 9.Side X., Donald C., Lindah H. Effects of fish oil on cytokines and immune functions of mice with murine AIDS. J Lipid Res. 1998;39:1677–1687. [PubMed] [Google Scholar]
- 10.Stark K., Park E., Maines V., Holub B. Effect of a fish-oil concentrate on serum lipids in post-menopausal women receiving and not receiving hormone replacement therapy. Am J Clin Nutr. 2000;72:389–394. doi: 10.1093/ajcn/72.2.389. [DOI] [PubMed] [Google Scholar]
- 11.Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma. Clin Chem. 1972;18:499–502. [PubMed] [Google Scholar]
- 12.Gaziano J.M., Hennekens C.H., O’Donnell C.J. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation. 1977;96:2520–2525. doi: 10.1161/01.cir.96.8.2520. [DOI] [PubMed] [Google Scholar]
- 13.Austin M.A., Hokanson J.E., Edwards K.L. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol. 1998;81:7–12. doi: 10.1016/S0002-9149(98)00031-9. [DOI] [PubMed] [Google Scholar]
- 14.Torres I., Mira L., Ornelas C., Melim A. Study of the effects of dietary fish intake on serum lipids and lipoproteins in two populations with different dietary habits. Br J Nutr. 2000;83:371–379. [PubMed] [Google Scholar]
- 15.Nestel P. Fish oil and cardiovascular disease: lipids and arterial function. Am J Clin Nutr. 2000;71:228–231. doi: 10.1093/ajcn/71.1.228S. [DOI] [PubMed] [Google Scholar]
- 16.Harris W.S. n-3 Fatty acids and serum lipoproteins: human studies. Am J Clin Nutr. 1997;65:1645–1654. doi: 10.1093/ajcn/65.5.1645S. [DOI] [PubMed] [Google Scholar]
- 17.Blok W., Katan M.B., Meer J.W. Modulation of inflammation and cytokine production by dietary (n-3) fatty acids. J Nutr. 1996;126:1515–1533. doi: 10.1093/jn/126.6.1515. [DOI] [PubMed] [Google Scholar]
- 18.Ariza Ariza R., Mestanza Peralta M., Cardiel M.H. Omega-3 fatty acids in rheumatoid arthritis: an overview. Semin Arthritis Rheum. 1998;27:366–370. doi: 10.1016/S0049-0172(98)80016-4. [DOI] [PubMed] [Google Scholar]
- 19.Nielsen A.A., Jorgensen L.G., Nielsen J.N., Eivindson M. Omega-3 fatty acids inhibit an increase of proinflammatory cytokines in patients with active Crohn’s disease compared with omega-6 fatty acids. Aliment Pharmacol Ther. 2005;22:1121–1128. doi: 10.1111/j.1365-2036.2005.02698.x. [DOI] [PubMed] [Google Scholar]
- 20.Deckelbaum R.J., Worgall T.S., Seo T. n-3 fatty acids and gene expression. Am J Clin Nutr. 2006;83:1520–1525. doi: 10.1093/ajcn/83.6.1520S. [DOI] [PubMed] [Google Scholar]